- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: abraxane
Total 557 results
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States, Australia
-
University of ChicagoNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Metastatic Pancreatic Adenocarcinoma | Malignant Gastrointestinal Neoplasm | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Gallbladder Carcinoma | Stage IV Gallbladder Cancer | Stage IV Gastric Cancer | Stage IIIA Gallbladder Cancer | Stage... and other conditionsUnited States
-
Nisha Mohindra, MDMerck Sharp & Dohme LLC; Hoosier Cancer Research Network; Celgene CorporationTerminated
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMetastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
University of California, San FranciscoAmgenActive, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Devalingam MahalingamAmgenWithdrawnPancreatic Cancer | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer | KRAS P.G12CUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); CelgeneActive, not recruitingResectable Cholangiocarcinoma | Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 | Stage II Intrahepatic Cholangiocarcinoma AJCC v8 | Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8United States
-
Brown UniversityRhode Island HospitalCompletedPancreatic Cancer | Locally Advanced Pancreatic CancerUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Lymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Neoplasm Metastasis | Hodgkin Disease | Pancreatic Adenocarcinoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head... and other conditionsUnited States
-
GWT-TUD GmbHAstraZeneca; CelgeneActive, not recruitingPancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreas CancerGermany
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Terminated
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
Pancreatic Cancer Action NetworkNovartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Spanish Breast Cancer Research GroupCelgeneCompleted
-
M.D. Anderson Cancer CenterCelgene Corporation; AmgenCompletedBreast CancerUnited States
-
MedSIRWithdrawn
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Nektar TherapeuticsTerminatedNon-Small Cell Lung CancerUnited States, Germany, Spain, Australia, France
-
FibroGenCompletedPancreatic Cancer (Unresectable)United States
-
Sun Yat-sen UniversityInnovent Biologics (Suzhou) Co. Ltd.; CSPC Pharmaceutical Group LimitedCompletedEfficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC PatientsEsophageal Squamous Cell CarcinomaChina
-
Samsung Medical CenterCompletedPancreatic Ductal AdenocarcinomaKorea, Republic of
-
OncoMed Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedResectable Pancreatic Carcinoma | Stage I Pancreatic Cancer AJCC v6 and v7 | Stage IA Pancreatic Cancer AJCC v6 and v7 | Stage IB Pancreatic Cancer AJCC v6 and v7 | Stage II Pancreatic Cancer AJCC v6 and v7 | Stage IIA Pancreatic Cancer AJCC v6 and v7 | Stage IIB Pancreatic Cancer AJCC v6 and v7United States
-
The Methodist Hospital Research InstituteCompletedBreast Cancer | Breast NeoplasmsUnited States
-
Jenny C. Chang, MDGE Healthcare; The Methodist Hospital Research InstituteWithdrawn
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Apexigen, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States
-
University of Colorado, DenverCompletedPancreatic CancerUnited States
-
Adrienne G. WaksMerck Sharp & Dohme LLCActive, not recruiting
-
Corcept TherapeuticsCompleted
-
University of Colorado, DenverCancer League of ColoradoWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | PD-L1 Gene MutationUnited States
-
US Oncology ResearchGenentech, Inc.TerminatedBreast Neoplasms | Malignant Tumor of the BreastUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Washington University School of MedicineGenentech, Inc.Terminated
-
Lisata Therapeutics, Inc.CompletedPancreatic Cancer | Pancreatic Ductal AdenocarcinomaAustralia
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
ERYtech PharmaCompletedPancreatic AdenocarcinomaUnited States, United Kingdom, France
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Massachusetts General HospitalNational Cancer Institute (NCI)Active, not recruitingGastroEsophageal CancerUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedSoft Tissue SarcomaSwitzerland
-
Alliance Foundation Trials, LLC.Bristol-Myers Squibb; Celgene CorporationTerminatedNonsmall Cell Lung Cancer | Non Small Cell Lung Cancer Recurrent | Non-Small Cell Carcinoma of Lung, TNM Stage 4 | Non-Small-Cell Lung Cancer MetastaticUnited States
-
Ludwig-Maximilians - University of MunichActive, not recruiting
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic Adenocarcinoma | Stage II Pancreatic Cancer AJCC v6 and v7 | Stage IIA Pancreatic Cancer AJCC v6 and v7 | Stage IIB Pancreatic Cancer AJCC v6 and...United States
-
Merck Sharp & Dohme LLCCompleted
-
GB006, Inc., a wholly owned subsidiary of Gossamer...Merck Sharp & Dohme LLCTerminatedRenal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Castration-resistant Prostate Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Adenocarcinoma | Esophageal... and other conditionsUnited States, United Kingdom
-
Wake Forest University Health SciencesCelgeneCompletedLung CancerUnited States
-
Brown UniversityLifespan; SouthCoast Medical Group; Memorial hospitalCompletedMetastatic Pancreatic CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawnOvarian Cancer | Endometrial Cancer | Recurrent Endometrial Cancer | Recurrent Ovarian Cancer